Several studies have focussed on peroxisome proliferator-activated receptor (PPAR) gamma co-activator 1 alpha (PGC-1α, encoded by PPARGC1A) as a potential treatment for mitochondrial disease. This evidence concerns the gene PPARGC1A and mitochondrial disease.